BIOTECHNOLOGY

Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries

Yourgene’s LightBench is an automated electrophoresis instrument, powered by Ranger® [...]

By |2023-11-17T10:29:12+00:00November 17, 2023|3rd Party Medical Device Industry News|Comments Off on Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries

AI Therapeutics Announces Investigator Initiated Phase 2 Trial at UCSF to Study LAM-001 in Patients With Bronchiolitis Obliterans Syndrome (BOS) Post-Lung Transplant

LAM-001 is a proprietary, investigational, inhaled formulation of sirolimus, also [...]

By |2023-08-18T17:05:06+00:00August 18, 2023|3rd Party Medical Device Industry News|Comments Off on AI Therapeutics Announces Investigator Initiated Phase 2 Trial at UCSF to Study LAM-001 in Patients With Bronchiolitis Obliterans Syndrome (BOS) Post-Lung Transplant

HiFiBiO Therapeutics Announces First Patient Dosed with HFB200301 in Combination with tislelizumab in Patients with DIS® Selected Advanced Solid Tumors

Liang Schweizer, PhD, Founder, CEO, and Chairperson of HiFiBiO Therapeutics, [...]

By |2023-06-23T15:46:45+00:00June 23, 2023|3rd Party Medical Device Industry News|Comments Off on HiFiBiO Therapeutics Announces First Patient Dosed with HFB200301 in Combination with tislelizumab in Patients with DIS® Selected Advanced Solid Tumors

Sorrento Therapeutics, Inc. announces a $4.6 Million U.S. Government Contract from the NIAID for a Sensitive, Reusable, and Rapid Diagnostic Platform for Pandemic Preparedness

“We are pleased to accept this award and collaboration with [...]

By |2023-06-13T19:49:18+00:00June 13, 2023|3rd Party Medical Device Industry News|Comments Off on Sorrento Therapeutics, Inc. announces a $4.6 Million U.S. Government Contract from the NIAID for a Sensitive, Reusable, and Rapid Diagnostic Platform for Pandemic Preparedness
Go to Top